| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0008 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |